First-of-its-Kind trial gives newborns antibody shots to block HIV
NCT ID NCT06517693
Summary
This study is testing the safety of two lab-made antibodies, given as shots to newborns who were exposed to HIV during birth. The goal is to see if these antibodies are safe for infants and to measure how long they stay in the body. Researchers will give the antibodies to 48 healthy newborns within their first few days of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 31890, Harare Family Care
NOT_YET_RECRUITINGHarare, Zimbabwe
-
Site 5013, Jacobi Medical Center Bronx
NOT_YET_RECRUITINGThe Bronx, New York, 10461, United States
-
Site 5030, Emory University School of Medicine
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
-
Site 5051, University of Florida Jacksonville
RECRUITINGJacksonville, Florida, 32209, United States
-
Site 5052, University of Colorado Denver
RECRUITINGAurora, Colorado, 80045, United States
-
Site 5072, Hospital Federal dos Servidores do Estado
NOT_YET_RECRUITINGRio de Janeiro, CEP 20221-903, Brazil
-
Site 5083, Rush University Cook County Hospital Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60612, United States
-
Site 5092, Johns Hopkins University Baltimore
RECRUITINGBaltimore, Maryland, 21287, United States
-
Site 5097, Hospital Geral De Nova Iguacu Brazil
NOT_YET_RECRUITINGRio de Janeiro, CEP 26030-380, Brazil
-
Site 5112, David Geffen School of Medicine at UCLA
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Site 5114, Bronx-Lebanon Hospital Center
RECRUITINGThe Bronx, New York, 10457, United States
-
Site 5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho
NOT_YET_RECRUITINGKericho, 20200, Kenya
-
Site 5127, Pediatric Perinatal HIV
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
-
Site 5128, Baylor College of Medicine/Texas Children's Hospital
RECRUITINGHouston, Texas, 77030, United States
-
Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research
NOT_YET_RECRUITINGSan Juan, 00935, Puerto Rico
-
Site 6501, St. Jude Children's Research Hospital
NOT_YET_RECRUITINGMemphis, Tennessee, 38105, United States
-
Site 8950, FAMCRU
NOT_YET_RECRUITINGCape Town, Parrow Valley, 7505, South Africa
Conditions
Explore the condition pages connected to this study.